Patents by Inventor Victor I. SELEDTSOV

Victor I. SELEDTSOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Xenogenic normal tissue-derived vaccines for breaking the immune tolerance to tumor-associated, antigens
    Patent number: 10695408
    Abstract: Disclosed is an antitumor vaccine including testicular and fetal tissue-derived components. Cell preparations are prepared from normal tissues harvested directly from animals. Such vaccines may be used in the treatment and prevention of different cancers. For example, a vaccine consisting of glutaraldehyde-treated cells prepared from sheep testis and fetal lung has been found to be effective in inducing antitumor cell-mediated responses, as well as in prolonging the survival of mice with lung cancer.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: June 30, 2020
    Assignee: UAB “Innovita Research”
    Inventors: Victor I. Seledtsov, Galina V. Seledtsova, Adas Darinskas
  • XENOGENIC NORMAL TISSUE-DERIVED VACCINES FOR BREAKING THE IMMUNE TOLERANCE TO TUMOR-ASSOCIATED, ANTIGENS
    Publication number: 20170296642
    Abstract: Disclosed is an antitumor vaccine including testicular and fetal tissue-derived components. Cell preparations are prepared from normal tissues harvested directly from animals. Such vaccines may be used in the treatment and prevention of different cancers. For example, a vaccine consisting of glutaraldehyde-treated cells prepared from sheep testis and fetal lung has been found to be effective in inducing antitumor cell-mediated responses, as well as in prolonging the survival of mice with lung cancer.
    Type: Application
    Filed: April 15, 2015
    Publication date: October 19, 2017
    Inventors: Victor I. SELEDTSOV, Galina V. SELEDTSOVA, Adas DARINSKAS